Corcept Therapeutics | CORT - Операционный доход





Операционный доход Изменить Дата
Acadia Pharmaceuticals USD -4.62M 22.01M 2026-03
Alaunos Therapeutics USD -1.01M 175K 2026-03
ANI Pharmaceuticals USD 38.71M 9.58M 2026-03
Ardelyx USD -32.79M 37.89M 2026-03
Aurora Cannabis CAD -10.03M 25.76M 2026-03
BioMarin Pharmaceutical USD 129.65M 68.74M 2026-03
Bristol-Myers Squibb USD 4.2B 562M 2025-12
Canopy Growth CAD -27.47M 14.81M 2026-03
Corcept Therapeutics USD -49.6M 54.09M 2026-03
Eli Lilly USD 9.78B 792M 2026-03
Esperion Therapeutics USD 85.23M 95.19M 2025-12
J&J USD 6.62B 1.03B 2026-03
Knight Therapeutics CAD 6.21M 3.27M 2025-12
Lexicon Pharmaceuticals USD -14.78M 2.59M 2025-12
Merck USD -1.88B 8.12B 2026-03
Nektar Therapeutics USD -19.09M 15.26M 2025-12
Novartis USD 4.24B 171M 2026-03
Novartis USD 4.24B 171M 2026-03
Omeros USD -35.41M 23.75M 2024-09
Pacira USD 4.62M 1.43M 2026-03
Pfizer USD 4.99B 340M 2026-03
Supernus Pharmaceuticals USD -35.25M 49.07M 2026-03
TG Therapeutics USD 34.8M 15.7M 2026-03